Ms. Philbin advises clients on regulatory and compliance issues including those related to clinical trials, pre-market submissions, the Quality System Regulation, Medical Device Reporting, recalls, product importing and exporting, and product promotion. Ms. Philbin assists clients in responding to agency investigations and in filing comments with FDA to respond to various regulatory initiatives. She reviews SEC filings of FDA-regulated companies and conducts due diligence of companies as part of mergers and acquisitions and initial public offerings. Ms. Philbin also assists in litigation.
Stephanie Philbin, a counsel in the firm’s FDA Group and a member of its Life Sciences Practice, concentrates on Food and Drug Administration laws. She joined Goodwin in 2007.
Ms. Philbin is a member of the D.C. Bar Association. She is on the advisory board of BNA, Inc.’s Medical Devices Law & Industry Report.
Prior to joining Goodwin, Ms. Philbin was counsel at Wilmer Cutler Pickering Hale and Dorr. Ms. Philbin is a former instructor at Georgetown University Law Center’s Foundations for Foreign Lawyers.
While in law school, Ms. Philbin served as the Articles Editor for the Georgetown Journal of Legal Ethics.
U.S. News - Best Lawyers®Biotechnology Law Firm of the Year
Georgetown University Law Center
College of the Holy Cross
(cum laude, Phi Beta Kappa)